Speaker: Dr Dave Leather Medical VP GSK Resp Global Therapy Area
Speaker: Prof Martin Gibson CEO, North West e-health
Facilitator: Dr Neil Snowise Visiting Senior Lecturer, Pharmaceutical Science, King’s College, London

Summary
In this interactive session we will cover the following concepts and topics:

• Drivers of effectiveness
• Designing Medicines to be effective
• The IMI get real initiative
• The current state of Electronic Health Records
• The potential of Electronic health Records in Effectiveness Research

Speaker: Dr Rav Seeruthun Medical Director, Roche UK
Speaker: Prof Ruth Plummer Clinical Professor of Experimental Cancer Medicine, Northern Institute for Cancer Research, Newcastle University
Facilitator: Dr Kam Nanuwa FPM Policy & Communications Group

Summary
Investigator-Initiated Studies (ISSs) and collaborative studies can be a vital component in the development of medicines, but it is important for companies to engage in the right way at the right time.

This workshop will explore, using specific examples of best practice, when IISs can best add value to company development programmes.

Speaker: Baroness Finlay Crossbench pear, House of Lords; Professor of palliative medicine, Cardiff University School of Medicine
Speaker: Dr Tony Lockett Visiting Lecturer Pharmaceutical Medicine, King’s College London
Facilitator: Renata Crome FPM Policy & Communications Group

Summary
A thorough appreciation of ethics is essential when running clinical trials. This workshop will explore some of the commonly encountered issues:

• How do you ensure appropriate diversity in clinical trial population?
• How should companies report failed trials and negative results?
• Will digital health and IT help or hinder informed consent?
• The ethics of trials in the developing world
• The ethics of consent in vulnerable populations